Krister Lindmark

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

European journal of clinical pharmacology

Open heart

Cardiovascular therapeutics

Journal of clinical medicine

Umeå University

Umeå Universitet Medicinska fakulteten (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Umeå University Jan 10 2017

Sweden

Assoc. Professor :: Public Health and Clinical Medicine

Västerbotten Läns Landsting Apr 01 2006

Sweden

Consultant :: Cardiology

Education History

Umeå Universitet Medicinska fakulteten Sep 01 1994 - Mar 31 2000

Sweden

PHD :: Histology and Cell biology

Publications

Helena Norberg, Therese Andersson, Erik Håkansson, Karin Hellström Ängerud, Krister Lindmark
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin. European journal of clinical pharmacology (2024)
Helena Norberg, Therese Andersson, Erik Håkansson, Karin Hellström Ängerud, Krister Lindmark
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin. European journal of clinical pharmacology 80 (9) (2024)
Helena Norberg, Therese Andersson, Erik Håkansson, Karin Hellström Ängerud, Krister Lindmark
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin. European journal of clinical pharmacology 80 (9) (2024)
Helena Norberg, Therese Andersson, Erik Håkansson, Karin Hellström Ängerud, Krister Lindmark
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin. European journal of clinical pharmacology 80 (9) (2024)
Erik Håkansson, Mattias Brunström, Helena Norberg, Sara Själander, Krister Lindmark
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study. Open heart 9 (2) (2023)
Anna Jonsson Holmdahl, Gustav Wessberg, Helena Norberg, Adrian Söderström, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark
Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population. Open heart 9 (2) (2023)
Erik Håkansson, Mattias Brunström, Helena Norberg, Sara Själander, Krister Lindmark
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study. Open heart 9 (2) (2023)
Anna Jonsson Holmdahl, Gustav Wessberg, Helena Norberg, Adrian Söderström, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark
Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population. Open heart 9 (2) (2023)
Petra Truedson, Michael Ott, Krister Lindmark, Malin Ström, Martin Maripuu, Robert Lundquist, Ursula Werneke
Effects of Toxic Lithium Levels on ECG-Findings from the LiSIE Retrospective Cohort Study. Journal of clinical medicine 11 (19) (2022)
Erik Håkansson, Helena Norberg, Sara Själander, Krister Lindmark
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population. Cardiovascular therapeutics 2021 (2021)
Helena Norberg, Ellinor Bergdahl, Karin Hellström Ängerud, Krister Lindmark
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study. European journal of clinical pharmacology 77 (1) (2020)
Anna Jonsson Holmdahl, Ida Viklund, Andreas Jonsson, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark, Helena Norberg
Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure. ESC heart failure 7 (3) (2020)
Helena Norberg, Veronica Pranic, Ellinor Bergdahl, Krister Lindmark
Differences in medical treatment and clinical characteristics between men and women with heart failure - a single-centre multivariable analysis. European journal of clinical pharmacology 76 (4) (2020)
Helena Norberg, Ellinor Bergdahl, Krister Lindmark
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors. Cardiovascular therapeutics 2019 (2019)
Anna Jonsson, Helena Norberg, Ellinor Bergdahl, Krister Lindmark
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population. Cardiovascular therapeutics 36 (5) (2018)

Krister Lindmark.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Krister Lindmark